In January 2022Rated as National Enterprise Technology Center
In January 2022the first and exclusive evaluation of the consistency of generic drug quality and efficacy was conducted in China for "Ropinilo Hydrochloride Tablets (0.5mg and 3mg)"
In January 2022 the first biopharmaceutical "BZ1001 project" of Zhi'en Biotechnology obtained a drug clinical trial license
In March 2022"Tadalafil Tablets (20mg)" won the drug registration certificate.
In March 2022the "Abercept Intraocular Injection Solution" officially obtained clinical implied permission
In May 2022the supplementary application for the process change of "tropisetron hydrochloride" API was approved by the National Medical Products Administration
In May 2022the Zhi'en Biopharmaceutical Conversion Center was completed and the biopharmaceutical project was officially put into operation
In May 2022the Cell Preparation Center of Zhi'en Translational Medicine Research Institute was officially put into operation
In June 2022,the construction of the factory building and supporting facilities for the Zhi'en Modern Traditional Chinese Medicine Project (Phase I) officially began
In June 2022 Orlistat (T12) production digital workshop was identified as Chongqing digital workshop in 2022
In June 2022Successfully docked with the top node of national identity analysis, and launched the construction of the characteristic industrial internet in the plant based biopharmaceutical industry
In July 2022 the subsidiary Chongqing Enchuang Medical Management Co., Ltd. was awarded the "Drug Production License"
In August 2022A joint venture agreement was officially signed with Baifan Biotechnology, and Feifan (Chongqing) Biopharmaceutical Co., Ltd. was officially registered
In September 2022 "Metformin Hydrochloride" was approved for commercial production
in September 2022Recognized as the fourth batch of national specialized, refined, and new "little giant" enterprises
in September 2022The Western Science City Biopharmaceutical High end Manufacturing Base Project was launched
In November 2022A strategic cooperation agreement was signed with Situofan to build a "life core valley" in the central and western regions
In November 2022Changshou A02 Workshop Orlistat production line officially passed the GMP compliance inspection
in November 2022Recognized as a national intellectual property demonstration enterprise
In November 2022Rated as one of the top 100 private manufacturing enterprises in Chongqing